Edison Tak‐bun Liu

Edison Tak‐bun Liu's AcademicInfluence.com Rankings

Edison Tak‐bun Liu

Biology

#12176

World Rank

#15634

Historical Rank

Computational Biology

#263

World Rank

#264

Historical Rank

Genetics

#1325

World Rank

#1427

Historical Rank

Neuroscience

#2025

World Rank

#2081

Historical Rank

biology Degrees

Download Badge

Biology

Edison Tak‐bun Liu's Degrees

PhD Genetics University of California, San Diego
Bachelors Biochemistry University of California, San Diego

Why Is Edison Tak‐bun Liu Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Edison Tak‐bun Liu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Transcriptional Landscape of the Mammalian Genome (2005) (3394)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study (2003) (2060)
International network of cancer genome projects (2010) (1839)
An Oestrogen Receptor α-bound Human Chromatin Interactome (2009) (1476)
Genome-wide analysis of mammalian promoter architecture and evolution (2006) (1317)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. (2005) (1301)
A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome (2006) (1172)
Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation (2012) (1142)
Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. (2007) (887)
CTCF-Mediated Human 3D Genome Architecture Reveals Chromatin Topology for Transcription (2015) (769)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts (2005) (762)
High-fidelity mRNA amplification for gene profiling (2000) (715)
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. (2006) (690)
RNA Viral Community in Human Feces: Prevalence of Plant Pathogenic Viruses (2005) (624)
Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells (1994) (615)
Evolution of the mammalian transcription factor binding repertoire via transposable elements. (2008) (480)
Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection (2003) (479)
Whole-Genome Cartography of Estrogen Receptor α Binding Sites (2007) (435)
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci (2010) (358)
Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. (2009) (356)
Transcriptome Analysis of Zebrafish Embryogenesis Using Microarrays (2005) (328)
Discovery of estrogen receptor α target genes and response elements in breast tumor cells (2004) (306)
Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. (2002) (296)
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients (2006) (294)
Telomerase directly regulates NF-κB-dependent transcription (2012) (294)
Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression (2006) (289)
Identification of c-myc responsive genes using rat cDNA microarray. (2000) (278)
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. (2002) (265)
Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation (2005) (262)
Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. (2005) (251)
DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. (2008) (227)
Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer (2002) (227)
Transcriptome Profiling of Human and Murine ESCs Identifies Divergent Paths Required to Maintain the Stem Cell State (2005) (217)
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. (1992) (215)
Regulation of Transcription through Acetylation of H3K122 on the Lateral Surface of the Histone Octamer (2013) (211)
Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. (2010) (208)
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy (2017) (203)
Initiating oncogenic event determines gene-expression patterns of human breast cancer models (2002) (196)
Identification of cell cycle-regulated genes in fission yeast. (2005) (193)
Mouse Models for Cancer Immunotherapy Research. (2018) (186)
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology (1995) (180)
Integrative model of genomic factors for determining binding site selection by estrogen receptor-α (2010) (179)
Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state (2011) (179)
Optimal gene expression analysis by microarrays. (2002) (178)
Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase (1996) (171)
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling (2005) (170)
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. (2006) (170)
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents (2001) (165)
BRCA1-associated growth arrest is RB-dependent. (1999) (165)
Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor α, in response to deacetylase inhibition by valproic acid and trichostatin A (2005) (160)
p53-regulated Transcriptional Program Associated with Genotoxic Stress-induced Apoptosis* (2004) (151)
Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. (2008) (150)
Receptor tyrosine kinases expressed in metastatic colon cancer (1995) (149)
Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway. (2001) (146)
RCP is a human breast cancer-promoting gene with Ras-activating function. (2009) (133)
Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. (2005) (132)
THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma (2005) (130)
Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. (2012) (130)
Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes (2003) (130)
Identification of a large Myc-binding protein that contains RCC1-like repeats. (1998) (129)
Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. (2010) (125)
Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. (2004) (118)
Genetic background is an important determinant of metastatic potential (2003) (115)
Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach (2004) (115)
Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. (2002) (115)
Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. (2002) (114)
GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma (2011) (114)
Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. (2002) (112)
p53 gene alterations in human prostate carcinoma. (1993) (112)
De-Novo Identification of PPARγ/RXR Binding Sites and Direct Targets during Adipogenesis (2009) (112)
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer (2007) (111)
The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations (2017) (110)
Global Expression Profiling Identifies Signatures of Tumor Virulence in MMTV-PyMT-Transgenic Mice (2004) (110)
Alterations of the P53 gene are associated with the progression of a human prostate carcinoma. (1992) (109)
5' Long serial analysis of gene expression (LongSAGE) and 3' LongSAGE for transcriptome characterization and genome annotation. (2004) (107)
Systems Biology, Integrative Biology, Predictive Biology (2005) (106)
Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles (2015) (106)
Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements* (2008) (100)
Large-Scale Functional Organization of Long-Range Chromatin Interaction Networks (2012) (100)
Systematic Deletion Analysis of Fission Yeast Protein Kinases (2005) (95)
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer (2012) (95)
Silencing of Wnt Signaling and Activation of Multiple Metabolic Pathways in Response to Thyroid Hormone-Stimulated Cell Proliferation (2001) (93)
Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family (2002) (93)
Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma (2003) (93)
Identification of Src transformation fingerprint in human colon cancer (2002) (92)
The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses. (2002) (91)
Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors (2005) (91)
BRCA1 Is a Selective Co-activator of 14-3-3ς Gene Transcription in Mouse Embryonic Stem Cells* 210 (2001) (91)
The tandem duplicator phenotype as a distinct genomic configuration in cancer (2016) (89)
Her-2/neu and Topoisomerase iiα in Breast Cancer (2003) (87)
Mechanism of tandem duplication formation in BRCA1 mutant cells (2017) (87)
Transcriptome kinetics of arsenic-induced adaptive response in zebrafish liver. (2006) (86)
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection (2004) (83)
Transcriptional consequences of genomic structural aberrations in breast cancer. (2011) (81)
Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes. (2011) (81)
Zebrafish Whole-Adult-Organism Chemogenomics for Large-Scale Predictive and Discovery Chemical Biology (2008) (78)
Microarrays and clinical investigations. (2004) (76)
Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. (1992) (76)
Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts. (2004) (76)
Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axl: potential role in autocrine signaling in cartilage. (1997) (73)
Novel protein kinases expressed in human breast cancer (1993) (72)
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy (2015) (69)
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma. (2010) (68)
Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003 (2004) (68)
Structural mutations in cancer: mechanistic and functional insights. (2012) (67)
Picky Comprehensively Detects High Resolution Structural Variants in Nanopore Long Reads (2018) (67)
Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of β-interleron gene in chronic myelogeneous leukemia (1990) (66)
Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. (2008) (66)
Expression of the matrix Gla protein in urogenital malignancies (1992) (62)
Interrogating the transcriptome. (2004) (61)
HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells (2007) (60)
Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors (2006) (60)
cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene. (2002) (58)
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators (2013) (58)
Gold-nanoparticle-based assay for instantaneous detection of nuclear hormone receptor-response elements interactions. (2010) (58)
Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites (2006) (56)
In the pursuit of complexity: systems medicine in cancer biology. (2006) (56)
Self-assembled monolayer-assisted silicon nanowire biosensor for detection of protein-DNA interactions in nuclear extracts from breast cancer cell. (2011) (55)
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping. (2003) (55)
Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer. (2006) (54)
A gene harvest revealing the archeology and complexity of human disease (2007) (54)
Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas (2004) (52)
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study (2006) (52)
Detection of Severe Acute Respiratory Syndrome Coronavirus in Blood of Infected Patients (2004) (52)
Oncogenes and Tumor Suppressor Genes in Human Malignancies (2012) (52)
Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals. (2004) (52)
BRCA1 Interacts with and Is Required for Paclitaxel-Induced Activation of Mitogen-Activated Protein Kinase Kinase Kinase 3 (2004) (51)
Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility (2010) (51)
Classification of cancers by expression profiling. (2003) (51)
Fine mapping of the 11q22–23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma (2004) (50)
Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. (1992) (49)
Gene Expression Profiling to Identify Oncogenic Determinants of Autocrine Human Growth Hormone in Human Mammary Carcinoma* (2005) (49)
Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer (2011) (48)
Linkage Disequilibrium Mapping of CHEK2: Common Variation and Breast Cancer Risk (2006) (47)
Q&A: ChIP-seq technologies and the study of gene regulation (2010) (47)
Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. (2002) (46)
Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance (2004) (45)
Topoisomerase IIα gene (TOP2A) amplification and deletion in cancer – more common than anticipated (2003) (45)
ESR1 and EGF genetic variation in relation to breast cancer risk and survival (2008) (45)
Detection of Chromosomal Breakpoints in Patients with Developmental Delay and Speech Disorders (2014) (45)
Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. (2007) (44)
Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine (2007) (43)
Activation of the Axl receptor tyrosine kinase induces mitogenesis and transformation in 32D cells. (1994) (42)
SARS Transmission Pattern in Singapore Reassessed by Viral Sequence Variation Analysis (2005) (42)
BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. (2001) (42)
Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma (2010) (42)
Characterization of Mice Deficient in the Src Family Nonreceptor Tyrosine Kinase Frk/rak (2002) (39)
Risk of breast cancer according to the status of HER-2/neu oncogene amplification. (2000) (39)
Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage‐independent growth properties and impact on global gene expression in esophageal carcinoma (2008) (38)
Breast cancer cell line proliferation blocked by the Src‐related Rak tyrosine kinase (2003) (38)
Heterogeneous epigenetic regulation of TIMP3 in prostate cancer (2012) (38)
Protein kinases in human breast cancer (1995) (37)
Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays. (2001) (35)
Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines (2011) (33)
Highly sensitive and reversible silicon nanowire biosensor to study nuclear hormone receptor protein and response element DNA interactions. (2010) (33)
BRCA1-mediated repression of select X chromosome genes (2004) (31)
A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. (2002) (31)
Monochromosome Transfer and Microarray Analysis Identify a Critical Tumor-Suppressive Region Mapping to Chromosome 13q14 and THSD1 in Esophageal Carcinoma (2008) (30)
HER2 as a predictor of therapeutic response in breast cancer. (2000) (30)
Identification of Myc-mediated Death Response Pathways by Microarray Analysis* (2002) (29)
Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study (2006) (29)
Systems consequences of amplicon formation in human breast cancer (2014) (29)
Identifying gene expression changes in breast cancer that distinguish early and late relapse among uncured patients (2006) (28)
HER-2/neu and topoisomerase IIalpha in breast cancer. (2003) (27)
Global Profiling of DNA Replication Timing and Efficiency Reveals that Efficient Replication/Firing Occurs Late during S-Phase in S. pombe (2007) (25)
Functional genomics of cancer. (2008) (25)
Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblast-specific regulation of the insulin-like growth factor binding protein 4 gene. (2008) (24)
HER-2/neu and topoisomerase IIalpha--simultaneous drug targets in cancer. (2003) (24)
FANCM regulates repair pathway choice at stalled replication forks. (2021) (23)
Susceptibility to cell death induced by blockade of MAPK pathway in human colorectal cancer cells carrying Ras mutations is dependent on p53 status. (2004) (23)
Of mice and CRISPR (2017) (22)
Mechanism-derived gene expression signatures and predictive biomarkers in clinical oncology. (2005) (22)
Effects of HER-2/neu on chemosensitivity of tumor cells. (2000) (21)
PPARG Binding Landscapes in Macrophages Suggest a Genome-Wide Contribution of PU.1 to Divergent PPARG Binding in Human and Mouse (2012) (21)
Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons (2012) (21)
The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity. (2004) (20)
Xenopus tropicalis Genome Re-Scaffolding and Re-Annotation Reach the Resolution Required for In Vivo ChIA-PET Analysis (2015) (20)
Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk. (2007) (19)
Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators (2017) (18)
Defining the galaxy of gene expression in breast cancer (2002) (18)
Company Says It Mapped Part of SARS Virus (2003) (17)
Pyrosequencing enhancement for better detection limit and sequencing homopolymers. (2010) (15)
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer (2011) (15)
Prediction of early distant relapses on tamoxifen in early-stage breast cancer (BC): A potential tool for adjuvant aromatase inhibitor (AI) tailoring (2005) (15)
Strategy for the design of custom cDNA microarrays. (2003) (15)
Primate-Specific Endogenous Cis-Antisense Transcription in the Human 5q31 Protocadherin Gene Cluster (2005) (15)
Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. (2015) (15)
BEARR: Batch Extraction and Analysis of cis-Regulatory Regions (2004) (14)
Of mice and CRISPR The post-CRISPR future of the mouse as a model system for the human condition (2017) (14)
Molecular oncodiagnostics: where we are and where we need to go. (2003) (14)
Gene profile and response to treatment. (2005) (13)
Juvenile myelomonocytic leukemia (JMML) with the hematologic phenotype of severe β thalassemia (1998) (13)
Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes (2007) (13)
Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study. (2003) (13)
P57 (KIP2) polymorphisms and breast cancer risk (1999) (13)
The Cinderella effect: searching for the best fit between mouse models and human diseases. (2013) (13)
Expression genomics and drug development: towards predictive pharmacology. (2005) (13)
High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts (2018) (13)
BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. (1996) (13)
FANCM regulates repair pathway choice at stalled replication forks (2020) (12)
Differential polymerase chain reaction in the analysis of gene dosage. (1993) (12)
Stromal effects in breast cancer. (2007) (12)
The Archon Genomics X PRIZE for whole human genome sequencing (2010) (12)
Integrative biology — a strategy for systems biomedicine (2009) (12)
Integrative biology and systems biology (2005) (12)
Judging the Archon Genomics X PRIZE for whole human genome sequencing (2011) (11)
Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014 (2017) (11)
Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection (2021) (10)
Oncogenes, breast cancer, and chemoprevention (1993) (10)
Corrigendum to: Integrative genomics of gene and metabolic regulation by estrogen receptors and, and their coregulators (Molecular Systems Biology, (2014), 9, 1, (676), 10.1038/msb.2013.28) (2017) (9)
Higher order structure in the cancer transcriptome and systems medicine (2007) (9)
Microarray Gene Expression Profiling of Angiogenesis Inhibitors Using the Rat Aortic Ring Assay (2002) (9)
Functional chromatin features are associated with structural mutations in cancer (2014) (8)
Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development (2009) (8)
Genomic and molecular classification of breast cancer (2006) (8)
Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia (2020) (8)
A bioinformatics tool to select sequences for microarray studies of mouse models of oncogenesis (2002) (8)
Cancer genomes. (2010) (7)
Expression genomics and cancer biology. (2004) (7)
CORRECTIONS (1994) (7)
Patient-Derived Tumor Xenografts: Why Now? (2016) (7)
Ha-ras rare alleles in breast cancer susceptibility (2004) (7)
Validation of Transgenic Mammary Cancer Models: Goals of the NCI Mouse Models of Human Cancer Consortium and the Mammary Cancer CD-ROM (2002) (7)
Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma (2012) (7)
Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes (2001) (6)
Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assay. (2002) (6)
Viruses and Oncogenes (1988) (6)
Long Span Paired-EndTag Mapping Reveals Characteristic Patterns of Structural Variations in Epithelial Cancer Genomes (2011) (6)
Cellular Regulatory Networks (2010) (5)
Subgenomic RNAs as molecular indicators of asymptomatic SARS-CoV-2 infection (2021) (5)
The Human Genome Organisation (HUGO) (2009) (5)
Personalized medicine: does the molecular suit fit? (2013) (5)
With a different voice: Integrating the psychosocial perspective into routine oncology care (1995) (5)
The role of ras gene mutations in myeloproliferative disorders. (1990) (4)
Gene Array Technologies in Biological Investigations (2005) (4)
Cellular Proto-oncogenes (1988) (4)
Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments. (2018) (4)
Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017) (4)
Expression genomics and cancer drug development (2004) (4)
Corrigendum: Genome-wide analysis of mammalian promoter architecture and evolution (2007) (4)
Growth Factors and Receptors (1988) (4)
Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia (2020) (3)
Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells. (2022) (3)
Reply to Watkins et al.: Whole-genome sequencing-based identification of diverse tandem duplicator phenotypes in human cancers (2016) (3)
New technologies for high-throughput analysis. (2005) (3)
General keynote: expression profiling and the study of ovarian cancer. (2003) (3)
The Genome Institute of Singapore (2005) (3)
Human genome meeting 2016 (2016) (3)
Oncogenes: An Introduction to the Concept of Cancer Genes (2012) (2)
src and Related Protein Kinases (1988) (2)
Oncogenes and Human Cancers (1988) (2)
Genomics takes hold in Asia. Interview by David Cyranoski. (2008) (2)
Core biopsy versus surgical tumor specimens for microarray analysis of gene expression profiles (2001) (2)
Personalized Cancer Medicine 2011: Toward Individualized Cancer Treatments. XV International Fritz Bender Symposium Held on February 21 to 23, 2011 at Matrix, Biopolis, Singapore. (2011) (2)
Animals, quality and the pursuit of relevance (2022) (2)
The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing. (2014) (2)
Functional Complementation and Gene Expression Profile Analysis Identified THSD1 at 13q14 as a Novel Candidate Tumor Suppressor Gene for Esophageal Squamous Cell Carcinoma (2008) (2)
Archon Genomics X PRIZE Validation Protocol (2011) (2)
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer (2022) (2)
Towards a causative function of histone modifications in regulation of chromatin dynamics and transcription (2013) (2)
Grappling with Cancer (2013) (2)
Tumor Origins Through Genomic Profiles. (2019) (2)
The Specialized Program of Research Excellence in breast cancer at the University of North Carolina at Chapel Hill (1995) (2)
Potential Diagnostic Uses of Oncogenes (1988) (2)
Molecular profiling of metastatic tumor progression of a murine squamous cell carcinoma by differential display and cDNA microarray reveals dysregulated expression of genes related to the nuclear factor-κb signal pathway (2001) (2)
myc and Other Nuclear Oncogenes (1988) (2)
BRCA1 Is a Selective Co-activator of 14-3-3s Gene Transcription in Mouse (2001) (2)
Genomic technologies and the interrogation of the transcriptome (2005) (2)
Personalizing medicine (2010) (2)
Expression profiling and breast cancer biology. (2004) (1)
Assays: Tools of the New Biology (1988) (1)
Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer (2017) (1)
Quantitative Biology and Clinical Trials: A Perspective (2010) (1)
A bioinformatics tool to mine sequences for microarray studies of mouse models of oncogenesis (1999) (1)
Employees’ Views and Ethical, Legal, and Social Implications Assessment of Voluntary Workplace Genomic Testing (2021) (1)
Functional chromatin features are associated with structural mutations in cancer (2014) (1)
Genome-wide analysis of mammalian promoter architecture and evolution (vol 38, pg 626, 2006) (2007) (1)
Genomic Technologies for Systems Biology (2010) (1)
Use of the Rat Gene Index to examine gene expression patterns from Src-transformed rat fibroblasts that exhibit broad differences in metastatic potential (1999) (1)
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer (2012) (1)
Clinical Genomicist in the Future of Medical Practice (2012) (1)
Abstract 5676: Patient-derived tumor xenografts in humanized NSG-SGM3 mice: An improved immuno-oncology platform (2018) (1)
CHAPTER 24 – Biobanking in the Post-Genome Era (2009) (0)
Oncogene Paradigm: Contribution to a Fundamental Understanding of Malignancy (1988) (0)
The impact of the bioethics advisory committee on the research community in Singapore (2010) (0)
Corrections (1965) (0)
Molecular characterization of an extensive lung cancer patient-derived xenograft (PDX) resource. (2014) (0)
Abstract B137: Oncogenic chromosomal blocks in cancer genomes. (2013) (0)
Representational oligonucleotide microarray analysis (ROMA) in pharmacogenomics (2004) (0)
Position Paper on the Testing of DNA and Tissue in Human Research (2002) (0)
Somatic genetics and signaling/genomics/proteomics (2003) (0)
Technology developments and applications (2009) (0)
Systems Biology in Cancer Medicine: Combinatorics and the Long Tail (2014) (0)
585 Genomics of Metastatic Progression in Cutaneous Melanoma (2012) (0)
Advances in Technology and Their Implications for Global Pharmaceutical Development (2006) (0)
HER-2/neu neu and topoisomerase IIα α in breast cancer (2003) (0)
Differential global effects of selective estrogen receptor modulators on estrogen receptor binding and transcriptional regulation (2007) (0)
SELF-ASSEMBLED MONOLAYER-ASSISTED SILICON NANOWIRE BIOSENSOR FOR STUDYING PROTEIN-DNA INTERACTIONS (2010) (0)
Abstract P6-06-02: Molecular characterization of a patient-derived xenograft (PDX) resource for triple negative breast cancer (2015) (0)
Abstract LB-32: Patient-derived xenograft (PDX) paraclinical platform to guide precision medicine in urothelial cancer (2014) (0)
Foundations for Systems Biomedicine (2009) (0)
Transgenic Mice: Direct In Vivo Assay for Oncogenes (1988) (0)
ras Family of Oncogenes (1988) (0)
A patient-derived xenograft (PDX) platform to optimize omics-driven precision medicine in bladder cancer. (2014) (0)
Discussion: Somatic Genetics and Signaling/Genomics/Proteomics (2003) (0)
Prospective study for comprehensive genomic profiling (GP) in cancer of unknown primary (CUP): Feasibility, molecular landscape, and clinical utility in current era. (2020) (0)
The Role of the Novel Nuclear Tyrosine Kinase, RAK, in Breast Cancer Biology (1997) (0)
Abstract P1-03-05: Patient-derived xenografts in humanized mice classify metastatic potential of primary triple negative breast cancer (2020) (0)
Identification of c-myc target genes using a rat cDNA microarray (1999) (0)
606 Defining the Molecular States of Cancer and Stem Cells Through Integrative Transcriptional and Genomic Analysis (2012) (0)
Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway (2015) (0)
Abstract 3180:In vitrotool for discovering oncogenes and tumor suppressor genes in a system's manner. (2013) (0)
283 P53 Mutations in Arylaminc- and Smoking-induced Human Bladder Cancer (1995) (0)
27th HUGO-IABCR Congress 2010: Oral Presentation Abstracts, 5–7 October 2010, Singapore (2010) (0)
SYSTEMS PHARMACOLOGY IN CANCER THERAPEUTICS: ITERATIVE INFORMATICS-EXPERIMENTAL INTERFACE (2008) (0)
Abstract IA29: Mice host selection for patient-derived xenograft (PDX) model development and other critical factors for success (2016) (0)
Genome-wide analysis of mammalian promoter architecture and evolution based upon human and mouse CAGE data, Supplementary Data (2006) (0)
Risk of Breast Cancer According to the Status of HER-2 / neu Oncogene Amplification 1 (2000) (0)
Abstract 2411: Evolution during propagation and treatment of patient-derived triple negative breast cancer xenografts (2016) (0)
Development and characterization of patient-derived xenografts to guide precision medicine in bladder cancer. (2015) (0)
Evolution of an intratumoral ecology susceptible to successive treatment in breast cancer xenografts (2018) (0)
Abstract 3414: Genomic signatures of melanoma maintenance (2014) (0)
Abstract 2909: High-precision quantification of clonal evolution during comparative treatments of triple negative breast cancer (2017) (0)
Mapping of the estrogen receptor: GATA-3 interactome in MCF-7 human mammary carcinoma cells (2007) (0)
A Chloroform-Assisted Protein Isolation Method Followed by Capillary NanoLC-MS Identify Estrogen-Regulated Proteins from MCF7 Cells (2010) (0)
Abstract IA13: The Patient-Derived Xenograft Program at The Jackson Laboratory (2016) (0)
Human T Cell Lymphotropic/Leukemia Viruses (1988) (0)
HGV2009 meeting: bigger and better studies provide more answers and more questions (2010) (0)
Utilization of a 358-gene panel to molecularly profile solid tumors for association with target-based therapeutic agents. (2014) (0)
Systems Pharmacology in Cancer (2010) (0)
Functional genomics of complex cancer genomes (2022) (0)
Q U E S T I O N & A N S W E R Open Access (2010) (0)
Epigenetic factors that control estrogen receptor alpha (ERα) binding site utilization and specificity in the MCF-7 human breast cancer cell line (2007) (0)
Understanding mechanism of estrogen receptor mediated gene regulation in MCF7 and Ishikawa cell lines (2007) (0)
Abstract GS1-05: Tandem duplicator phenotypes define 50% of triple negative breast cancers (2018) (0)
SILICON NANOWIRE BIOSENSOR FOR STUDYING NUCLEAR HORMONE RECEPTOR AND RESPONSE ELEMENT INTERACTIONS (2010) (0)
Xenograft Platform Could Lead to Mouse-Based Clinical Trials (2018) (0)
Commentary Defining the galaxy of gene expression in breast cancer (2002) (0)
Questions about comparative genomics of SARS coronavirus isolates (2003) (0)
Transcriptional Regulation and Cancer Genomics (2008) (0)
Mammary gland involution studies with cDNA microarrays (1999) (0)
Dose-and Time-dependent Effects Camptothecin-induced DNA Damage : Microarray Analysis of Transcriptional Regulation of Mitotic Genes by Updated (2002) (0)
Genome-Wide Dynamics of Chromatin Binding of Estrogen Receptors (cid:1) and (cid:2) : Mutual Restriction and Competitive Site Selection (2009) (0)
Abstract 3998: The role of serum amyloid A1 (SAA1) in nasopharyngeal carcinoma (NPC) (2012) (0)
Singapore tissue network in supporting biomedical research in Singapore (2007) (0)
Abstract 4947: Analysis of structural mutations in cancer genomes (2012) (0)
Towards a causative function of histone modifications in regulation of chromatin dynamics and transcription (2013) (0)
PPARg/RXR transcriptional circuitry governing adipocyte biology (2007) (0)
The emergence of ‘The HUGO Journal’ (2009) (0)
Oncogenic Human Papi Homa virus Type 16 Is Associated with Squamous Cell Cancer of the Male Urethra 1 (2006) (0)
Patient-derived xenograft platform to guide precision medicine in bladder cancer. (2015) (0)
Abstract 114: Study of the high-grade ovarian cancer precursors in the oviduct (2012) (0)
Abstract 5107: Unravelling the complexity of individual cancer genomes (2012) (0)
Differential gene expression in cells with targeted deletion of BRCA1 tumor suppressor (2001) (0)
Potential Therapeutic Applications of Oncogenes (1988) (0)
Gene expression in prostate cancer: microarray analysis of tumor specimens from African American and Caucasian patients (2001) (0)
transcriptome and genome analyses Next-generation DNA sequencing of paired-end tags ( PET ) for (2009) (0)
Patient-derived bladder cancer xenografts as a platform for drug development in bladder cancer. (2015) (0)
Silencing of Wnt signaling and activation of multiple metabolic pathways in response to cell proliferation stimulated by thyroid hormone (2001) (0)
Abstract 2001: Genomic signatures of melanoma progression and maintenance. (2013) (0)
Gene expression profiles of low- and high-grade papillary serous ovarian carcinomas using cDNA microarray analysis (2001) (0)
- Axl: Axl protein-tyrosine kinase (vertebrates) [UFO (human, mouse), Ark (mouse)] (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Edison Tak‐bun Liu?

Edison Tak‐bun Liu is affiliated with the following schools:

Edison Tak‐bun Liu's Academic­Influence.com Rankings

Edison Tak‐bun Liu's Degrees

Why Is Edison Tak‐bun Liu Influential?

Edison Tak‐bun Liu's Published Works

Published Works

What Schools Are Affiliated With Edison Tak‐bun Liu?

Edison Tak‐bun Liu's AcademicInfluence.com Rankings